Study of Unani formulation in decrease thyroid function.
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: null- Hypothyroidism
- Registration Number
- CTRI/2018/02/011768
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed cases of hypothyroidism
Patient having the TSH range between 5.5-15mU/L.[2]
Free T4 and T3 in normal reference range (Free T4: 0.9-2ng/dl and T3: 80-220ng/dl[1] )
Patient between the age of 20-60 years
Either gender (male & female)
Exclusion Criteria
Pregnancy and lactating women
Patients age below 20 and above 60 year
All complicated case of Hypothyroidism including primary and secondary hypothyroidism
Patient with H/o metabolic disorders and other systemic illness
Recent thyroid surgery or radio-iodine intake
Patient unable to give consent and who fail to follow-up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid Stimulating Hormone(TSH) <br/ ><br>Free T4 and T3 estimation <br/ ><br>Timepoint: Before and after treatment <br/ ><br>
- Secondary Outcome Measures
Name Time Method Tiredness <br/ ><br>Cold intolerance <br/ ><br>Constipation <br/ ><br>Weight gain <br/ ><br>Loss of hair <br/ ><br>Timepoint: Before treatment, 15th day, 30th day and after treatment